Less glucose variability with insulin detemir compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring

被引：0

|

作者：

Jones, David R.

Clauson, Per

Ong, Stephanie

Mathieu, Chantal

机构：

来源：

DIABETES | 2006年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A118 / A118

页数：1

相关论文

共 50 条

[1] Insulin detemir shows a lower glucose variability compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring
Jones, D. R.
Clauson, P.
Ong, S.
Mathieu, C.
DIABETOLOGIA, 2006, 49 : 580 - 580
[2] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
Heise, T
Nosek, L
Draeger, E
Ronn, BB
Kapitza, C
Heinemann, L
DIABETOLOGIA, 2003, 46 : A6 - A7
[3] Significant reduction in blood glucose variability with insulin detemir versus NPH insulin: Confirmed by meta-analysis of continuous glucose monitoring
Russell-Jones, D
Hermansen, K
Kim, H
Draeger, E
DIABETOLOGIA, 2004, 47 : A307 - A307
[4] Significant reduction in blood glucose variability with insulin detemir versus NPH insulin: Confirmed by meta-analysis of continuous glucose monitoring
Hermansen, K
Olsen, KJ
Draeger, E
DIABETES, 2004, 53 : A104 - A104
[5] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
Robertson, K. J.
Schoenle, E.
Gucev, Z.
Mordhorst, L.
Gall, M. -A.
Ludvigsson, J.
DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
[6] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
Russel-Jones, D
Bolinder, J
Simpson, R
Stades, A
Stender, A
Hylleberg, B
Draeger, E
DIABETES, 2003, 52 : A132 - A132
[7] Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
Kolendorf, K.
Ross, G. P.
Pavlic-Renar, I.
Perriello, G.
Philotheou, A.
Jendle, J.
Gall, M-A.
Heller, S. R.
DIABETIC MEDICINE, 2006, 23 (07) : 729 - 735
[8] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
Heise, T
Nosek, L
Draeger, E
Stender, A
Ronn, BB
Kapitza, C
Heinemann, L
DIABETES, 2003, 52 : A121 - A121
[9] Insulin Detemir Increases Cerebral Glucose Metabolism Compared to NPH Insulin in Human Type 1 Diabetes: Possible Explanation for Differences in Weight Gain?
Van Golen, Larissa W.
Huisman, Marc C.
Ijzerman, Richard G.
Hoetjes, Nikie J.
Schwarte, Lothar A.
Schober, Patrick
Hoogma, Roel P.
Drent, Madeleine L.
Lammertsma, Adriaan A.
Diamant, Michaela
DIABETES, 2011, 60 : A421 - A421
[10] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
Haak, T
Tiengo, A
Draeger, E
Suntum, M
Waldhäusl, W
DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64

← 1 2 3 4 5 →